BLA
AMAG

Balter Liquid Alternatives’s AMAG Pharmaceuticals AMAG Stock Holding History

Balter Liquid Alternatives’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,952
Closed -$139K – 264
2018
Q3 		$139K Hold
6,952
– – 0.11% 158
2018
Q2 		$138K Sell
6,952
-43,629
-86% -$965K 0.11% 174
2018
Q1 		$1.02M Buy
50,581
+41,545
+460% +$703K 0.97% 21
2017
Q4 		$120K Buy
+9,036
New +$136K 0.12% 151

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Balter Liquid Alternatives's AMAG Position: Q4 2018 in Review

Balter Liquid Alternatives sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 6,952 shares — an estimated $139K sold.

Balter Liquid Alternatives first reported a position in AMAG in Q4 2017 and held it in 4 quarters. The position peaked at $1.02M in Q1 2018. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

  • Balter Liquid Alternatives reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Balter Liquid Alternatives sold 6,952 AMAG Pharmaceuticals shares in Q4 2018, an estimated $139K.
  • Balter Liquid Alternatives first reported a position in AMAG Pharmaceuticals in Q4 2017 and held it in 4 quarters.
  • Balter Liquid Alternatives's AMAG Pharmaceuticals position peaked at $1.02M in Q1 2018.
  • 190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on Balter Liquid Alternatives's 13F filing for Q4 2018, filed 8 Feb 2019.